Anagin's Grant

Anagin raised a round of funding on October 09, 2014. Investors include National Institutes of Health.

Anagin is developing first-in-class novel targeted therapies for addressing pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. Suc…

Articles about Anagin's Grant: